1:1 adducts of sickle hemoglobin
US9248199B2 · kind B2 · utility
42Cited by
0References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 29, 2014 |
| Grant date | Feb 2, 2016 |
| Priority date | — |
| Expiry date | Apr 8, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/42
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provide herein are 1:1 adducts of sickle hemoglobin (HbS) and a compound of formula (I), as defined herein, suitable as modulators of HbS, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.